AMPH FY 2020 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$350M+8.5% YoY

Gross Profit

$143M41.0% margin

Operating Income

$11M3.1% margin

Net Income

$1M0.4% margin

EPS (Diluted)

$0.03

Cash Flow

Operating Cash Flow

$57M

Free Cash Flow

$23M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$631M

Total Liabilities

$183M

Stockholders' Equity

$402M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$350M	$322M	+8.5%
Gross Profit	$143M	$132M	+8.7%
Operating Income	$11M	-$39,000	+28187.2%
Net Income	$1M	$49M	-97.1%